Navigation Links
ASCO and ASH Release Updated Guideline on the Use of Chemotherapy-Related Anemia Treatments in Cancer Patients
Date:10/22/2007

WASHINGTON, Oct. 22 /PRNewswire-USNewswire/ -- Today, the American Society of Hematology (ASH) and the American Society of Clinical Oncology (ASCO) have released an updated joint guideline on the use of erythropoiesis-stimulating agents (ESAs), a class of drugs that stimulate the bone marrow to produce more red blood cells, to treat chemotherapy-related anemia.

"One goal of these guidelines is to inform clinicians with the most up-to-date evidence from high-quality studies regarding the risks and benefits of ESAs in patients with cancer," said J. Douglas Rizzo, MD, MS, co-chair of the guideline panel and Associate Professor of Medicine, Medical College of Wisconsin.

This updated guideline, originally published in 2002, was derived from systematic reviews and analysis of published clinical trials. It outlines the clotting risks of ESAs, makes recommendations on usage, and provides insights on disease progression and patient survival.

Specifically, the guideline:

-- Declares epoetin and darbepoetin equally safe and effective.

-- Recommends the use of ESAs as a treatment option for cancer patients

who become anemic as a result of chemotherapy when their hemoglobin

approaches or falls below 10 g/dL, as well as for patients with low-

risk myelodysplasia.

-- Suggests that when using ESAs, hemoglobin can be raised to (or near)

a concentration of 12 g/dL at which point the dosage should be

titrated to maintain that level. Dose reductions are also recommended

when hemoglobin rise exceeds 1 g/dL in any two-week period or when

the hemoglobin level exceeds 11 g/dL.

-- Recommends discontinuing use of ESAs beyond six to eight weeks if a

patient has not responded to the drug.

-- Recommends monitoring the iron levels of patients being treated with

ESAs and providing supplements accordingly.

-- Cautions against using ESAs for cancer patient
'/>"/>

SOURCE American Society of Hematology
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
2. Mayo Clinic News Release: Mayo Clinic-led Study Improves Breast Cancer Risk Prediction in Women with Atypia
3. Lupus Foundation of America Statement on Results for Clinical Study of CellCept Released by Aspreva Pharmaceutical Company
4. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
5. Phase IIIb Clinical Data Validate the Overall and Cardiovascular Safety Profile of Cycloset (A Quick Release Formulation of Bromocriptine Mesylate) in Patients with Type 2 Diabetes
6. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
7. VeroScience Late-Breaking Abstract on Cycloset (A Quick Release Formulation of Bromocriptine Mesylate) Accepted for Poster Presentation at American Diabetes Association 67th Scientific Sessions
8. Critical Therapeutics Announces the Publication of Data for ZyfloCR (Zileuton) Extended-Release Tablets in the Journal of Asthma
9. OREXIGEN Therapeutics Announces Sustained-Release Formulation of Zonisamide Shows Improved Tolerability When Compared to Immediate Release Formulation
10. New Research Confirms the Benefit of Extended-Release Dipyridamole Plus ASA for Preventing Recurrent Stroke in Low- and High-Risk Patients
11. Shire Announces Positive Results of Studies With Guanfacine Extended Release, An Investigational Nonstimulant Medication Filed for the Treatment of ADHD in Children and Adolescents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... 19, 2014 Larry J. Merlo , President ... will speak before the National Press Club in ... recent move to stop selling tobacco products and its leadership ... health. "Dramatic changes in our health care system ... government," Merlo has said. "CVS Health has a truly unique ...
(Date:9/19/2014)... 19, 2014  BioSpecifics Technologies Corp. (NASDAQ: BSTC ... marketed as XIAFLEX ® in the U.S. and XIAPEX ... Tom Wegman , will present a corporate overview at ... Industry Conference. The presentation will take place ... the Millennium Broadway Hotel in New York, NY ...
(Date:9/19/2014)... LOS ANGELES , Sept. 19, 2014  CytRx ... and development company specializing in oncology, today announced that ... will present at BioCentury,s 2014 NewsMakers in the Biotech ... p.m. Eastern Time. The conference will take place at ... City . A live and archived ...
Breaking Medicine Technology:CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 2CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 3BioSpecifics Technologies Corp. to Present at the 21st Annual BioCentury NewsMakers in the Biotech Industry Conference 2CytRx to Present at BioCentury's 2014 NewsMakers in the Biotech Industry Conference 2CytRx to Present at BioCentury's 2014 NewsMakers in the Biotech Industry Conference 3
... FRANKLIN LAKES, N.J., Nov. 12 Research presented at ... Annual Scientific Meeting shows that an intervention to reduce ... compromising patient safety and can result in substantial cost ... ) today released results of a study that examined ...
... Pharmaceuticals, Inc. (Nasdaq: TSPT ), a specialty pharmaceutical ... products that address important therapeutic needs in neuroscience, today ... ended September 30, 2009. , Transcept previously ... a Complete Response Letter regarding the New Drug Application ...
Cached Medicine Technology:New Research Shows Over-use of Asthma Rescue Inhalers Substantially Reduced Through Pharmacist-initiated Physician Intervention 2New Research Shows Over-use of Asthma Rescue Inhalers Substantially Reduced Through Pharmacist-initiated Physician Intervention 3Transcept Pharmaceuticals Reports Third Quarter 2009 Financial Results 2Transcept Pharmaceuticals Reports Third Quarter 2009 Financial Results 3Transcept Pharmaceuticals Reports Third Quarter 2009 Financial Results 4Transcept Pharmaceuticals Reports Third Quarter 2009 Financial Results 5Transcept Pharmaceuticals Reports Third Quarter 2009 Financial Results 6Transcept Pharmaceuticals Reports Third Quarter 2009 Financial Results 7Transcept Pharmaceuticals Reports Third Quarter 2009 Financial Results 8Transcept Pharmaceuticals Reports Third Quarter 2009 Financial Results 9Transcept Pharmaceuticals Reports Third Quarter 2009 Financial Results 10Transcept Pharmaceuticals Reports Third Quarter 2009 Financial Results 11Transcept Pharmaceuticals Reports Third Quarter 2009 Financial Results 12
(Date:9/21/2014)... (PRWEB) September 21, 2014 More ... have been added over the past month to ... allege serious cardiovascular injuries caused by the dialysis ... List updated on September 15th shows 2,089 cases ... U.S. District Court, District of Massachusetts. These claims ...
(Date:9/21/2014)... Md. (PRWEB) September 21, 2014 Faculty and ... with a coed preschool in Owings Mills, Md., kicked off ... with Garmin Vivofit bands. GFS is the first independent school ... taken, calories burned and even sleep patterns— as part of ... Baltimore area running and walking specialty chain. The Vivofit bands ...
(Date:9/20/2014)... Recently, UWDress.com, a professional company of women’s ... its newly announced evening cocktail dresses . As ... occasion outfits are very popular among worldwide customers. Now, ... savings (up to 65 percent off). , All ... special occasion outfits for the global clients. The company ...
(Date:9/20/2014)... Mexico (PRWEB) September 20, 2014 The ... including Villa del Palmar Cabo San Lucas, Villa La ... relation to Hurricane Odile, with plans to welcome guests ... , As of Sept. 19, all members and guests ... home, thanks to a coordinated effort with government authorities. ...
(Date:9/20/2014)... Loma Linda, CA (PRWEB) September 20, 2014 ... Center will receive a $250,000 pediatric cancer research grant ... event at Loma Linda University Children’s Hospital located on ... support the work of Dr. Kimberley Payne, Associate Professor ... Dr. Payne’s work focuses on leukemia in children. ...
Breaking Medicine News(10 mins):Health News:Federal GranuFlo Litigation Adds Dozens of Cases Alleging Serious Cardiovascular Injuries, Bernstein Liebhard LLP Reports 2Health News:Federal GranuFlo Litigation Adds Dozens of Cases Alleging Serious Cardiovascular Injuries, Bernstein Liebhard LLP Reports 3Health News:Federal GranuFlo Litigation Adds Dozens of Cases Alleging Serious Cardiovascular Injuries, Bernstein Liebhard LLP Reports 4Health News:Garrison Forest School Leader in Independent School Wellness Programs 2Health News:Cheap Evening Cocktail Dresses Recently Introduced At UWDress.com 2Health News:Villa Group Resorts in Cabo Largely Unharmed, Plan to Re-open Early October 2Health News:Loma Linda University Medical Center Receives $250,000 Research Grant From Hyundai Hope On Wheels In Honor Of National Childhood Cancer Awareness Month 2Health News:Loma Linda University Medical Center Receives $250,000 Research Grant From Hyundai Hope On Wheels In Honor Of National Childhood Cancer Awareness Month 3
... , TUESDAY, Jan. 4 (HealthDay News) -- Nearly 60 ... victims of violence, abuse or crime in the past year. ... happened. Researchers led by David Finkelhor of the University ... parents of children up to 9 years old in 2008. More ...
... Reporter , TUESDAY, Jan. 4 (HealthDay News) -- Common ... stem cell defect, a finding that could potentially lead ... study reveals. Researchers say they discovered that a ... stem cells turn into hair-producing progenitor cells. That defect, ...
... , TUESDAY, Jan. 4 (HealthDay News) -- The ... (arrhythmias) that can cause sudden death may be underestimated, ... healthy people without heart disease found detectable changes in ... to polluted air. The findings suggest that air ...
... Jan. 4 (HealthDay News) -- Levels of schooling may affect ... heart attack called acute ST-segment elevation myocardial infarction (STEMI), a ... of heart attack, STEMI occurs when the coronary artery is ... heart. In the new study, Dr. Rajendra H. ...
... Reporter , TUESDAY, Jan. 4 (HealthDay News) -- Simply measuring ... how many years they have left. In fact, a ... older people,s future life span about as well as taking ... disease. Walking speed may not be a perfect window ...
... YORK (Jan. 4, 2011) Researchers have produced a lasting anti-cocaine ... bits of the common cold virus with a particle that mimics ... published Jan. 4 in the online edition of Molecular Therapy ... researchers say this novel strategy might be the first to offer ...
Cached Medicine News:Health News:Survey Finds Much Victimization of Children Goes Unreported 2Health News:Stem Cell Defect Might Help Spur Common Baldness 2Health News:Stem Cell Defect Might Help Spur Common Baldness 3Health News:Higher Education May Benefit Some Heart Attack Patients 2Health News:Fast Walkers May Have More Years Ahead of Them 2Health News:Fast Walkers May Have More Years Ahead of Them 3Health News:Vaccine blocks cocaine high in mice 2Health News:Vaccine blocks cocaine high in mice 3
... Ergonomic Design for Unparalleled Comfort ... it. Notice the balance. Notice the trigger and ... left-handed. Thats because our pipettors are ergonomically designed ... long hours of pipetting. Productivity In The ...
... ergonomic solution and best value in high ... action and ultra lightweight design reduce hand ... with long, lever tip ejector , Color ... universal tips or for greater performance use ...
... The Research pro Electronic Pipette is ideal ... laboratory. Its easy-to-follow display, ergonomically-placed operating buttons, ... dispensing, reverse pipetting and diluting make this ... simple functions of a manual pipette without ...
... Transfer an Entire Column of a ... efficiency and throughput with 384 well plates, you ... narrow well spacing. Thats exactly what you get ... or Impact2 software (see Impact/Impact2), this innovation was ...
Medicine Products: